GS

Gerhard Siemeister

BP Bayer Pharma: 38 patents #1 of 819Top 1%
BG Bayer Intellectual Property Gmbh: 25 patents #21 of 1,266Top 2%
SC Schering: 9 patents #342 of 2,442Top 15%
BA Bayer Schering Pharma Ag: 4 patents #56 of 464Top 15%
BH Bayer Healthcare: 2 patents #3,312 of 8,007Top 45%
Overall (All Time): #27,093 of 4,157,543Top 1%
73
Patents All Time

Issued Patents All Time

Showing 51–73 of 73 patents

Patent #TitleCo-InventorsDate
9133171 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group Ulrich Lücking, Dirk Kosemund, Arne Scholz, Philip Lienau, Ulf Bömer +1 more 2015-09-15
9108926 Disubstituted 5-fluoro-pyrimidines Ulrich Lücking, Dirk Kosemund, Arne Scholz, Philip Lienau, Ulf Bömer +1 more 2015-08-18
8993630 Substituted sulphonamido phenoxybenzamides Ingo Hartung, Marion Hitchcock, Florian Pühler, Roland Neuhaus 2015-03-31
8916557 Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines Ulrich Lücking, Rolf Bohlmann, Arne Scholz, Mark Jean Gnoth, Ulf Bömer +4 more 2014-12-23
8802686 Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine Ulrich Lücking, Philip Lienau, Rolf Jautelat, Julia Schulze 2014-08-12
8735412 Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine Ulrich Lücking, Rolf Jautelat, Julia Schulze, Philip Lienau 2014-05-27
8729082 Substituted imidazoquinoxalines Marcus Koppitz, Benjamin Bader, Ulf Bömer, Bertolt Kreft, Philip Lienau +3 more 2014-05-20
8551980 Substituted triazolopyridines Volker Schulze, Marcus Koppitz, Dirk Kosemund, Benjamin Bader, Philip Lienau +4 more 2013-10-08
8524722 Substituted tricyclic compounds and methods of use thereof Hartmut Schirok, Ying Li-Sommer, Michael Brands, Mario Lobell, Adrian Tersteegen +8 more 2013-09-03
8507510 Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents Ulrich Lücking, Martin Kruger, Rolf Jautelat 2013-08-13
7943629 Sulphimides as protein kinase inhibitors Ulrich Luecking, Duy Nguyen, Arne Von Bonin, Oliver von Ahsen, Rolf Jautelat +1 more 2011-05-17
7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents Thomas Brumby, Rolf Jautelat, Olaf Prien, Martina Schäfer, Ulrich Lücking +1 more 2009-10-06
7511059 Thiazolidinones, their production and use as pharmaceutical agents Volker Schulze, Knut Eis, Lars Wortmann, Dirk Kosemund, Olaf Prien +3 more 2009-03-31
7456191 N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents Ulrich Luecking, Rolf Jautelat 2008-11-25
7378406 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases Jens Hoffmann, Rosemarie Lichtner, Martin Schneider, Ulrike Fuhrmann 2008-05-27
7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents Ulrich Luecking, Martin Krueger, Rolf Jautelat 2008-03-04
7335775 Effector conjugates, process for their production and their pharmaceutical use Markus Berger, Ulrich Klar, Jörg Willuda, Andreas Menrad, Klaus Bosslet 2008-02-26
7312225 Macrocyclic pyrimidines, their production and use as pharmaceutical agents Ulrich Luecking, Martina Schaefer, Hans Briem 2007-12-25
7291624 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents Thomas Brumby, Rolf Jautelat, Olaf Prien, Martina Schäfer, Ulrich Lücking +1 more 2007-11-06
7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents Ulrich Lücking, Martin Kruger, Rolf Jautelat, Olaf Prien, Alexander Ernst 2007-10-30
7235561 Compound and a composition including such a compound Thomas Brumby, Rolf Jautelat, Olaf Prien, Martina Schäfer, Ulrich Lücking +1 more 2007-06-26
7129254 Effector conjugates, process for their production and their pharmaceutical use Markus Berger, Ulrich Klar, Jörg Willuda, Andreas Menrad, Klaus Bosslet 2006-10-31
6747046 Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents Martin Kruger, Olaf Prien, Andreas Steinmeyer, Jorg Kroll, Alexander Ernst +2 more 2004-06-08